Cognitive domains affected post-COVID-19; a systematic review and meta-analysis.

Journal: European journal of neurology

Volume: 

Issue: 

Year of Publication: 

Affiliated Institutions:  Department of Psychiatry, University of Oxford, Oxford, UK. Barts Health NHS Trust, London, UK. School of Life and Medical Sciences, University College London, London, UK. Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Department of Brain Sciences, Imperial College London, London, UK. Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK. Division of Psychiatry, University College London, London, UK. NHS Greater Glasgow and Clyde, Glasgow, UK. Mbeya College of Health and Allied Sciences, University of Dar es Salaam, Mbeya, Tanzania. Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK. Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK. Department of Psychology, University of Liverpool, Liverpool, UK.

Abstract summary 

This review aims to characterize the pattern of post-COVID-19 cognitive impairment, allowing better prediction of impact on daily function to inform clinical management and rehabilitation.A systematic review and meta-analysis of neurocognitive sequelae following COVID-19 was conducted, following PRISMA-S guidelines. Studies were included if they reported domain-specific cognitive assessment in patients with COVID-19 at >4 weeks post-infection. Studies were deemed high-quality if they had >40 participants, utilized healthy controls, had low attrition rates and mitigated for confounders.Five of the seven primary Diagnostic and Statistical Manual of Mental Disorders (DSM-5) cognitive domains were assessed by enough high-quality studies to facilitate meta-analysis. Medium effect sizes indicating impairment in patients post-COVID-19 versus controls were seen across executive function (standardised mean difference (SMD) -0.45), learning and memory (SMD -0.55), complex attention (SMD -0.54) and language (SMD -0.54), with perceptual motor function appearing to be impacted to a greater degree (SMD -0.70). A narrative synthesis of the 56 low-quality studies also suggested no obvious pattern of impairment.This review found moderate impairments across multiple domains of cognition in patients post-COVID-19, with no specific pattern. The reported literature was significantly heterogeneous, with a wide variety of cognitive tasks, small sample sizes and disparate initial disease severities limiting interpretability. The finding of consistent impairment across a range of cognitive tasks suggests broad, as opposed to domain-specific, brain dysfunction. Future studies should utilize a harmonized test battery to facilitate inter-study comparisons, whilst also accounting for the interactions between COVID-19, neurological sequelae and mental health, the interplay between which might explain cognitive impairment.

Authors & Co-authors:  Fanshawe Jack B JB Sargent Brendan F BF Badenoch James B JB Saini Aman A Watson Cameron J CJ Pokrovskaya Aleksandra A Aniwattanapong Daruj D Conti Isabella I Nye Charles C Burchill Ella E Hussain Zain U ZU Said Khanafi K Kuhoga Elinda E Tharmaratnam Kukatharmini K Pendered Sophie S Mbwele Bernard B Taquet Maxime M Wood Greta K GK Rogers Jonathan P JP Hampshire Adam A Carson Alan A David Anthony S AS Michael Benedict D BD Nicholson Timothy R TR Paddick Stella-Maria SM Leek Charles E CE

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  26
Identifiers
Doi : 10.1111/ene.16181
SSN : 1468-1331
Study Population
Male,Female
Mesh Terms
Other Terms
COVID-19;attention;cognition;cognitive impairment;executive function;language;learning;memory
Study Design
Narrative Study
Study Approach
,Systemic Review
Country of Study
Publication Country
England